Neosperience

Share Issue/Capital Change • May 19, 2023

Informazione Regolamentata n. 20149-16-2023		Data/Ora Ricezione 19 Maggio 2023 08:05:44	Euronext Growth Milan
Societa'	:	NEOSPERIENCE
Identificativo Informazione Regolamentata	:	177247
Nome utilizzatore	:	NEOSPERIENCEN01 - Scaravelli
Tipologia	:	REGEM
Data/Ora Ricezione	:	19 Maggio 2023 08:05:44
Data/Ora Inizio Diffusione presunta	:	19 Maggio 2023 08:05:45
Oggetto	:	Health	NSP Shareholders meeting Neosperience
Testo del comunicato

Vedi allegato.

PRESS RELEASE

NEOSPERIENCE HEALTH, CONTROLLED BY NEOSPERIENCE SPA, APPROVES PLAN TO ACCESS FOREIGN CAPITAL MARKETS

Not for Distribution to U.S. Newswire Services or For Dissemination in the United States

Milan, 19 May 2023 – Neosperience S.p.A. ("Neosperience" or "NSP"), an innovative software vendor and a reference player in Artificial Intelligence, listed on Euronext Growth Milan, announces that the extraordinary shareholders' meeting of Neosperience Health S.p.A. ("NH"), 90% owned by NSP, has approved yesterday a capital increase aimed at accessing the U.S. capital markets. Following the completion of the process to access the U.S. capital markets, NSP is expected to continue to exercise control over NH.

NH plans to access U.S. capital markets and list on a national securities exchange concurrent with an offering of shares that will be deriving from the capital increase approved yesterday. On this point, the shareholders' meeting resolved to increase the share capital by issuing up to 100,000,000 shares that can be issued in the future also for further fundraising either in Italy or in foreign capital markets, including the U.S., to implement its strategy.

The shareholders' meeting also approved a new "articles of association" whose effectiveness is suspensively conditioned upon a U.S. listing.

Neosperience Health, established in May 2022, has inherited the activities carried out in recent years by NSP in the health sector and has recently developed a Neosperience Health Cloud software platform aimed at diagnostic centers, public and private hospitals, that allows the digitalization of patients' diagnosis, prevention and care, thanks to the use of advanced Artificial Intelligence algorithms.

With the proceeds of planned capital-raising activities in the U.S., NH intends to accelerate its growth, in Italy and the central European countries, while laying the foundations for development in the US market.

This press release does not constitute an offer of any securities of NSP or NH.

***

Neosperience Health S.p.A is an innovative digital health startup. Its mission is to evolve the patient experience and improve the patient's journey end-to-end: from aiding diagnosis, to optimizing data analysis, to improving prognosis. Its proprietary modular platform, Neosperience Health Cloud

(NHC), helps clinicians, patients, and healthcare organizations by combining advanced technologies – such as artificial intelligence and the Natural Language Processing – with an empathic approach.

www.neosperience.health

Neosperience is an innovative SME listed on Euronext Growth Milan that operates as a software vendor in artificial intelligence for digital customer experience and operational processes. Recently named by Gartner among the world's six most innovative software vendors, together with Adobe, Salesforce and SAS, Neosperience was founded in Brescia in 2006 by Dario Melpignano and Luigi Linotto, respectively, President and Executive Vice President. The Company focuses on Artificial Intelligence technology and applications with Neosperience Cloud: a proprietary software platform that allows companies to use AI to innovate business and operating models and improve the customer experience to increase revenues and margins. Neosperience's 800+ clients include leading companies in the fashion, retail, healthcare, manufacturing, and financial services sectors.

www.neosperience.com

Further information:

INVESTOR RELATIONS	SPECIALIST
Neosperience S.p.A.	MiT Sim S.p.A.
Lorenzo Scaravelli	Gianni Eusebio gianni.eusebio@mitsim.it + 39 02 305 61 276
ir@neosperience.com	Andrea Scarsi andrea.scarsi@mitsim.it + 39 02 305 61 276
+39 335 7447604
	EURONEXT GROWTH ADVISOR
IR Top Consulting	CFO SIM S.p.A.
ir@irtop.com + 39 02 4547 3883/4	ecm@cfosim.com +39 02 303431

Forward-looking Information

This press release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forwardlooking information. In some cases, forward-looking information can be identified by words or phrases such as "may," "will," "expect," "likely", "should," "would," "plan," "anticipate," "intend," "potential," "proposed," "estimate," "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy. The forward-looking information contained herein includes, without limitation, statements regarding the NSP, NH, and the business and strategic plans of each Company.

By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations, and opinions of management on the date such forward-looking information is made. Neither NSP or NH undertakes any obligation to update or revise any forward-looking information, whether because of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forwardlooking information, except as required by applicable law.